科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Bioethics2025-11-28· Corporate governance

Neurotechnology Governance in the United States: Gaps and Opportunities

Laura Y. Cabrera, Nia Evereteze, Emily G. Shank, Jennifer K. Wagner, Michele Mekel, Jennifer B. McCormick, Megan S. Wright

原始摘要(英文原文)· Original abstract
Neuroscience's accelerating advances have reached a pivotal point in the study of the human brain, including neurotechnologies capable of recording large amounts of data and acting with greater precision. However, the use of neurotechnology has raised a number of ethical, legal, and social implications (ELSI). To that end, sufficiently robust policy and governance structures must be considered. To date, no published review of United States policies governing neuroscience and neurotechnology exists. To address this, we review US polices and various ethical frameworks overseeing neuroscience and neurotechnology. This policy review highlights where gaps in neuroscience and neurotechnology policy and governance might exist. Overall, our review shows that "soft policies" make up the present-day US neurotech-governance universe at the federal level, with neurodata specific state-legislation emerging. The included analysis can aid researchers, technology developers, neuroethicists, research ethicists, legal scholars, and others in facilitating ethically and socially responsible implementation of neuroscience and neurotechnology as they move from "bench to bedside and beyond."
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Neurotechnology Governance in the United States: Gaps and Opportunities — 科研速览 Science Skim